Sarepta Therapeutics (SRPT) Work In Process (2022 - 2026)

Sarepta Therapeutics' Work In Process history runs 5 years deep, the most recent figure standing at $981.0 million for Q1 2026.

• In Q1 2026, Work In Process rose 28.71% year-over-year to $981.0 million; the TTM figure through Mar 2026 stood at $981.0 million (up 28.71% YoY), while the FY2025 annual figure was $892.7 million, up 46.18% from the prior year.
• Work In Process was $981.0 million for Q1 2026 at Sarepta Therapeutics, up from $892.7 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $981.0 million in Q1 2026 to a low of $269.2 million in Q4 2022.
• Historically, Work In Process has averaged $647.5 million across 5 years, with a median of $686.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Work In Process rose 18.3% in 2023, then surged 91.77% in 2024.
• A 5-year view of Work In Process shows it stood at $269.2 million in 2022, then advanced by 18.3% to $318.5 million in 2023, then soared by 91.77% to $610.7 million in 2024, then surged by 46.18% to $892.7 million in 2025, then gained by 9.9% to $981.0 million in 2026.
• The last three Work In Process figures came in at $981.0 million (Q1 2026), $892.7 million (Q4 2025), and $885.4 million (Q3 2025), per Business Quant data.